Development of anti-infliximab antibody is associated with reduced efficacy and infusion reaction in Behçet's disease with uveitis

被引：0

作者：

Ishigatsubo Y. ^{[1
,2
,3
]}

Takeno M. ^{[1
,3
,4
]}

Kirino Y. ^{[1
,3
]}

Mizuki N. ^{[3
,5
]}

机构：

[1] Yokohama City University Graduate School of Medicine, Department of Internal Medicine and Clinical Immunology, Yokohama

[2] Yokosuka City Hospital, Rheumatic Diseases Center, Yokosuka

[3] Behcet's Disease Research Committe, Yokohama

[4] Nihon Medical School Graduate School of Medicine, Department of Allergy and Rheumatology, Tokyo

[5] Yokohama City University Graduate School of Medicine, Department of Ophtalmology, Yokohama

来源：

关键词：

Infliximab; Uveitis; Adalimumab; Trough Level; Infusion Reaction;

D O I：

10.1186/1546-0096-13-S1-P166

中图分类号：

学科分类号：

摘要：

[No abstract available]

引用